Thrombosis |
2ß1 Integrin and Development of Atherosclerosis in a Mouse Model
From the Departments of Pathology & Immunology (D.G.G., S.A.S., M.M.Z.), Medicine (T.C., C.F.S.), and Cell Biology and Physiology (C.F.S.), Washington University School of Medicine, St Louis, Mo.
Correspondence to Mary M. Zutter, Department of Pathology, Vanderbilt University School of Medicine, C-3321A, 1161 21st Ave S, Nashville, TN 37232-2561. E-mail mary.zutter{at}vanderbilt.edu
Objectives The
2ß1 integrin serves as a collagen or collagen/laminin receptor on many cell types, including endothelial cells and platelets. Many studies indicate that the
2ß1 integrin is a critical mediator of platelet adhesion to collagen. Epidemiologic studies suggest a direct correlation between the genetically determined platelet surface density of the
2ß1 integrin and the risk of thrombotic diseases, such as myocardial infarction and stroke, in the young, which are well-established complications of atherosclerosis. We have now used the
2ß1 integrindeficient mouse to evaluate the contributions of the
2ß1 integrin to the development of atherosclerosis.
Methods and Results We generated wild-type (
2+/+) or
2ß1 integrindeficient (
2-/-) mice that were also deficient in the apolipoprotein E (ApoE) gene (ApoE-/-) and compared atherosclerotic lesion development in
2+/+ ApoE-/- and
2-/- ApoE-/- mice that were fed a high-fat, cholesterol-containing diet for 6 or 15 weeks. Total lesional area did not differ significantly between the
2-null animals and the wild-type animals at either 6 or 15 weeks.
Conclusions Our results suggest that risk for arterial thrombotic disease associated with high-level
2ß1 integrin expression is not attributable to enhanced development of atherosclerosis per se but may rather be a consequence of thrombotic complications at the plaques.
Key Words:
2ß1 integrin collagen atherosclerosis thrombosis
This article has been cited by other articles:
![]() |
L. Zhu, T. J. Stalker, K. P. Fong, H. Jiang, A. Tran, I. Crichton, E. K. Lee, K. B. Neeves, S. F. Maloney, H. Kikutani, et al. Disruption of SEMA4D Ameliorates Platelet Hypersensitivity in Dyslipidemia and Confers Protection Against the Development of Atherosclerosis Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1039 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Adiguzel, P. J Ahmad, C. Franco, and M. P Bendeck Collagens in the progression and complications of atherosclerosis Vascular Medicine, February 1, 2009; 14(1): 73 - 89. [Abstract] [PDF] |
||||
![]() |
A. L. Pyle, J. B. Atkinson, A. Pozzi, J. Reese, B. Eckes, J. M. Davidson, D. L. Crimmins, and P. P. Young Regulation of the Atheroma-Enriched Protein, SPRR3, in Vascular Smooth Muscle Cells through Cyclic Strain is Dependent on Integrin {alpha}1{beta}1/Collagen Interaction Am. J. Pathol., November 1, 2008; 173(5): 1577 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Franco, G. Hou, P. J. Ahmad, E. Y.K. Fu, L. Koh, W. F. Vogel, and M. P. Bendeck Discoidin Domain Receptor 1 (Ddr1) Deletion Decreases Atherosclerosis by Accelerating Matrix Accumulation and Reducing Inflammation in Low-Density Lipoprotein Receptor-Deficient Mice Circ. Res., May 23, 2008; 102(10): 1202 - 1211. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |